280
Views
50
CrossRef citations to date
0
Altmetric
CONTENTS

In vitro assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas

, , , , , , & show all
Pages 182-194 | Received 03 Sep 2009, Accepted 21 Jun 2010, Published online: 23 Aug 2010

References

  • Albrecht C, Scherbart AM, van Berlo D, Braunbarth CM, Schins RPF, Scheel J. 2009. Evaluation of cytotoxic effects and oxidative stress with hydroxyapatite dispersions of different physicochemical properties in rat NR8383 cells and primary macrophages. Toxicol In Vitro 23(3):520–530.
  • Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:5–24.
  • Borm PJ, Kelly F, Kunzli N, Schins RP, Donaldson K. 2007. Oxidant generation by particulate matter: From biologically effective dose to a promising, novel metric. Occup Environ Med 64:73–74.
  • Cai Y, Tang R. 2008. Calcium phosphate nanoparticles in biomineralization and biomaterials. J Mater Chem 18(32):3775–3787.
  • Curtis A. 2004. Tutorial on the biology of nanotopography, IEEE Trans Nanobiosci 3:293.
  • Das GK, Chan PPY, Teo A, Loo JSC, MJ, Anderson, Tan TTY. 2009. J Biomed Mater Res A 93(1):337–346.
  • Donaldson K, Stone V, Borm PJ, Jimenez LA, Gilmour PS, Schins RP, Knaapen AM, Rahman I, Faux SP, Brown DM, MacNee W. 2003. Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10). Free Radic Biol Med 34:1369–1382.
  • Donaldson K, Stone V, Tran CL, Kreyling W, Borm P. 2004. Nanotoxicology. Occup Environ Med 61:727–728.
  • Donaldson K, Tran CL. 2002. An introduction to the short-term toxicology of respirable industrial fibres. Tran Inhal Toxicol 14:5.
  • Fu Q, Mohamed R, Zhou N, Huang W, Wang D, Zhang L, Li HF. 2008. In vitro study on different cell response to spherical hydroxyapatite nanoparticles. J Biomat App 23(1):37–50.
  • Furuzono T, Walsh D, Sato K, Sonoda K, Tanaka J. 2001. Effect of reaction temperature on the morphology and size of hydroxyapatite nanoparticles in an emulsion system. J Mater Sci Lett 20(2):111–114.
  • Greenspan DC. 1999. Bioactive ceramic implant materials. Curr Opin Solid St M 4(4):389–393.
  • Han YLJ, Loo SCJ, Phung NT, Ong HT, Russell SJ, Peng KW, Boey F, Ma J. 2008. Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping. J Mater Sci Mater Med 19(9):2993–3003.
  • Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM. 1999. Dihydrofluorescein diacetate is superior for detection intracellular oxidants: Comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 27:146–159.
  • Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K. 1997. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44(7):1299–1305.
  • Kelly FJ. 2003. Oxidative stress: Its role in air pollution and adverse health effects. Occup Environ Med 60:612–616.
  • Koutsopoulos S, Dalas E. 2000a. Inhibition of hydroxyapatite formation in aqueous solutions by amino acids with hydrophobic side groups. Langmuir 16(16):6739–6744.
  • Koutsopoulos S, Dalas E. 2000b. The crystallization of hydroxyapatite in the presence of lysine. J Colloid Interface Sci 231(2):207–212.
  • Koutsopoulos S, Dalas E. 2001. Hydroxyapatite crystallization in the presence of amino acids with uncharged polar side groups: Glycine, cysteine, cystine, and glutamine. Langmuir 17(4):1074–1079.
  • Li B, Guo B, Fan H, Zhang X. 2008. Preparation of nano-hydroxyapatite particles with different morphology and their response to highly malignant melanoma cells in vitro. Appl Surf Sci 255(2):357–360.
  • Loo J, Siew Y, Ho S, Boey F, Ma J. 2008. Synthesis and hydrothermal treatment of nanostructured hydroxyapatite of controllable sizes. J Mater Sci: Mater Med 19:1389–1397.
  • Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–627.
  • Ong HT, Loo JSC, Harvey ME, Boey FYC, Russell SJ, Ma J, Peng KW. 2008. Exploiting the high affinity phosphonate-hydroxyapatite nanoparticle interaction for delivery of radiation and drugs. J Nanopart Res 10(1):141–150.
  • Pacurari M, Yin XJ, Zhao J, Ding M, Leonard SS, Schwegler-Berry D, Ducatman BS, Sbarra D, Hoover MD, Castranova V, Vallyathan VR. 2008. Single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-B, and Akt in normal and malignant human mesothelial cells. Environ Health Perspect 116(9):1211–1217.
  • Pezzatini S, Solito R, Morbidelli L, Lamponi S, Boanini E, Bigi A, Ziche M. 2006. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions J Biomed Mater Res A 176(3):656–663.
  • Qin L, Block ML, Liu Y, Bienstock RJ, Pei Z, Zhang W, Wu X, Wilson B, Burka T, Hong JS. 2005. Microglial NADPH oxidase is a novel target for femtomolar neuroprotective against oxidative stress. FASEB J 19:550–557.
  • Rouahi M, Champion E, Gallet O, Jada A, Anselme K. 2006. Physico-chemical characteristics and protein adsorption potential of hydroxyapatite particles: Influence on in vitro biocompatibility of ceramics after sintering. Colloids Surf B: Biointerfaces 47:10.
  • Schimmer RC, Schrier DJ, Flory CM, Dykens J, Tung DK, Jacobson PB, Friedl HP, Conroy MC, Schimmer BB, Ward PA. 1997. Streptococcal cell wall-induced arthritis Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. J Immunol 159(8):4103–4108.
  • Seah R, Garland M, Loo JSC, Widjaja E. 2009. Use of Raman microscopy and multivariate data analysis to observe the biomimetic growth of carbonated hydroxyapatite on bioactive glass. Analy Chem 81(4):1442–1449.
  • Streicher RM, Scbmidt M, Fiorito S. 2007. Nanosurfaces and nanostructures for artificial orthopedic implants. Nanomedicine 2(6):861–874.
  • Tanaka H, Miyajima K, Nakagaki M, Shimabayashi S. 1991. Incongruent dissolution of hydroxyapatite in the presence of phosphoserine. Colloid Polym Sci 269(2):161–165.
  • Walsh D, Kingston JL, Heywood BR, Mann S. 1993. Influence of monosaccharides and related molecules on the morphology of hydroxyapatite. J Cryst Growth 133(1–2):1–12.
  • Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi HJ, Yeh JI, Zink JI, Nel AE. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dssolution and oxidative stress properties. ACS Nano 2 (10):2121–2134.
  • Zhao YF, Loo SCJ, Ma J. 2009. Co-synthesis and drug delivery properties of hydroxyapatite-silica composites. J Nanosci Nanotechnol 9(6):3720–3727.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.